• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct16
Guobang Pharma released FY2025 9 Months Earnings on October 16 After-Market (BJT), actual revenue CNY 4.47 B, actual EPS CNY 1.2109
01:00
Guobang Pharma released FY2025 Q3 earnings on October 16 After-Market (BJT), actual revenue CNY 1.444 B, actual EPS CNY 0.3898
01:00
Oct9
Guobang Pharma FY2025 Q3 Earnings Release on October 17 After-Market BJT
00:08
Jul29
Guobang Pharma released FY2025 Q2 earnings on July 29 After-Market (BJT), actual revenue CNY 1.586 B, actual EPS CNY 0.4411
01:00
Guobang Pharma released FY2025 Semi-Annual Earnings on July 29 After-Market (BJT), actual revenue CNY 3.026 B, actual EPS CNY 0.82
01:00
Jul22
Guobang Pharma to Release FY2025 Semi-Annual Earnings on July 30, 2025 (BJT)
00:23

Schedules & Filings

Schedules
Filings
Oct16
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 1.444 B, Net Income 214.67 M, EPS 0.3898

Jul30
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Jul29
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 1.586 B, Net Income 240.59 M, EPS 0.4411

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More